Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-22-019773

Chief Financial Officer sold 7,500 shares at $235.00 ($1,762,500)

  • Chief Financial Officer acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sandercock Brett Chief Financial Officer 2022-07-22 Option exercise +2,500 $57.76 $144,400 108,926 D
Sandercock Brett Chief Financial Officer 2022-07-22 Option exercise +2,500 $57.76 $144,400 111,426 D
Sandercock Brett Chief Financial Officer 2022-07-22 Option exercise +2,500 $57.76 $144,400 113,926 D
Sandercock Brett Chief Financial Officer 2022-07-22 Sale −7,500 $235.00 $1,762,500 106,426 D
Derivatives
Sandercock Brett Chief Financial Officer 2022-07-22 Option exercise · ResMed Common Stock Options −2,500 7,500 D
Sandercock Brett Chief Financial Officer 2022-07-22 Option exercise · ResMed Common Stock Options −2,500 5,000 D
Sandercock Brett Chief Financial Officer 2022-07-22 Option exercise · ResMed Common Stock Options −2,500 2,500 D
Open-market sales · 7,500 sh · avg $235.00 · $1,762,500
Loading xslF345X03/form4.xml…